Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Clinically relevant changes in family history of cancer over time.

Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE.

JAMA. 2011 Jul 13;306(2):172-8. doi: 10.1001/jama.2011.955.

2.

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

Sirovich BE, Schwartz LM, Woloshin S.

JAMA. 2003 Mar 19;289(11):1414-20.

PMID:
12636464
3.

Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts.

Cardwell CR, Mc Menamin ÚC, Hicks BM, Hughes C, Cantwell MM, Murray LJ.

BMC Med. 2014 Feb 13;12:28. doi: 10.1186/1741-7015-12-28.

4.

Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.

Mai PL, Wideroff L, Greene MH, Graubard BI.

Public Health Genomics. 2010;13(7-8):495-503. doi: 10.1159/000294469. Epub 2010 Apr 9.

5.

A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network.

Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke C, Hill DA, Ahnen DJ.

Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):601-10. doi: 10.1158/1055-9965.EPI-13-1085. Epub 2014 Feb 5.

6.

Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.

Leu M, Reilly M, Czene K.

J Natl Cancer Inst. 2008 Sep 17;100(18):1318-25. doi: 10.1093/jnci/djn290. Epub 2008 Sep 9.

7.

Family history and prostate cancer risk in a population-based cohort of Iowa men.

Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP.

Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):53-60.

8.

Cancer screening rates in individuals with different life expectancies.

Royce TJ, Hendrix LH, Stokes WA, Allen IM, Chen RC.

JAMA Intern Med. 2014 Oct;174(10):1558-65. doi: 10.1001/jamainternmed.2014.3895.

PMID:
25133746
9.

Breast, colorectal, and skin cancer screening practices and family history of cancer in U.S. women.

Shah M, Zhu K, Palmer RC, Jatoi I, Shriver C, Wu H.

J Womens Health (Larchmt). 2007 May;16(4):526-34.

PMID:
17521256
10.

Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.

Sellers TA, Potter JD, Rich SS, Drinkard CR, Bostick RM, Kushi LH, Zheng W, Folsom AR.

J Natl Cancer Inst. 1994 Dec 21;86(24):1860-5.

PMID:
7990161
11.

Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.

Chen YC, Page JH, Chen R, Giovannucci E.

Prostate. 2008 Oct 1;68(14):1582-91. doi: 10.1002/pros.20825.

12.

Performance of screening mammography among women with and without a first-degree relative with breast cancer.

Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, Malvin K, Ernster V, Urban N, Cutter G, Rosenberg R, Ballard-Barbash R.

Ann Intern Med. 2000 Dec 5;133(11):855-63.

PMID:
11103055
13.

Colonoscopic surveillance for family history of colorectal cancer: are NHMRC guidelines being followed?

Yusoff IF, Hoffman NE, Ee HC.

Med J Aust. 2002 Feb 18;176(4):151-4.

PMID:
11913913
14.

Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives.

Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Nomura AM, Kolonel LN.

Am J Epidemiol. 2004 Apr 15;159(8):750-8.

15.

Disparities in cancer screening in individuals with a family history of breast or colorectal cancer.

Ponce NA, Tsui J, Knight SJ, Afable-Munsuz A, Ladabaum U, Hiatt RA, Haas JS.

Cancer. 2012 Mar 15;118(6):1656-63. doi: 10.1002/cncr.26480. Epub 2011 Aug 25.

16.

Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.

Samadder NJ, Curtin K, Tuohy TM, Rowe KG, Mineau GP, Smith KR, Pimentel R, Wong J, Boucher K, Burt RW.

Gastroenterology. 2014 Oct;147(4):814-821.e5; quiz e15-6. doi: 10.1053/j.gastro.2014.07.006. Epub 2014 Jul 17.

PMID:
25042087
17.

Confirmation of family cancer history reported in a population-based survey.

Mai PL, Garceau AO, Graubard BI, Dunn M, McNeel TS, Gonsalves L, Gail MH, Greene MH, Willis GB, Wideroff L.

J Natl Cancer Inst. 2011 May 18;103(10):788-97. doi: 10.1093/jnci/djr114. Epub 2011 May 11.

18.

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.

J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. doi: 10.1093/jnci/djr500. Epub 2012 Jan 6.

19.

Association between documented family history of cancer and screening for breast and colorectal cancer.

Carney PA, O'Malley JP, Gough A, Buckley DI, Wallace J, Fagnan LJ, Morris C, Mori M, Heintzman JD, Lieberman D.

Prev Med. 2013 Nov;57(5):679-84. doi: 10.1016/j.ypmed.2013.08.031. Epub 2013 Sep 9.

20.
Items per page

Supplemental Content

Write to the Help Desk